comparemela.com

Latest Breaking News On - Stefan oscarson - Page 1 : comparemela.com

UCD spin-out Aer Therapeutics raises $36m in funding round

Aer Therapeutics, a joint University College Dublin (UCD) and University of California, San Francisco (UCSF) spin-out company, has raised $36m (€32.6m) in series A funding.

North carolinaUnited statesSan franciscoAnne marie healyStefan oscarsonJim shafferJohn fahyTrinity college dublinSchool of chemistryUniversity college dublinUniversity of californiaAer therapeuticsHatteras ventureProfessor stefan oscarsonProfessor anne marie healy

Irish-founded Aer Therapeutics raises $36m for COPD treatment

Founded by researchers based in UCD and San Francisco, Aer is developing a novel drug to help COPD patients breathe easier.

United statesSan franciscoNorth carolinaJohn fahyAnne marie healyStefan oscarsonTrinity college dublinUniversity of californiaSchool of chemistry at university college dublinAer therapeuticsDubliner prof john fahyProf stefan oscarsonUniversity college dublinProf anne marie healyTrinity collegeHatteras venture

UCD spin-out Aer Therapeutics raises $36m in funding

Company was co-founded by Irishman Prof John Fahy of University of California, San Francisco and Prof Stefan Oscarson of UCD

United statesSan franciscoStefan oscarsonJohn fahyUniversity of californiaUniversity college dublinAer therapeuticsIrishman prof john fahyProf stefan oscarsonHatteras venture

Aer Therapeutics Closes $36 Million Series A Funding Round to Advance Development of an Innovative Mucolytic for the Treatment of Lung Diseases

Aer Therapeutics, a joint University College Dublin and University of California, San Francisco biopharmaceutical spin-out company developing novel in..

North carolinaUnited statesSan franciscoJohn fahyJim shafferTim shannonChristy shafferAnne marie healyThomas mathersStefan oscarsonUniversity of californiaNational institutes of healthSchool of chemistryTrinity college dublinUniversity college dublinAer therapeutics

Aer Therapeutics bags €32 7M to develop treatment for mucus-associated lung diseases: Know more

Aer Therapeutics, a biopharmaceutical spin-out company has secured $36M (approximately €32.7M) in a Series A round of funding.

United statesSan franciscoChristy shafferAnne marie healyJohn fahyThomas mathersStefan oscarsonTim shannonJim shafferTrinity college dublinUniversity of californiaSchool of chemistryBlood instituteUniversity college dublinNational institutes of healthNational institutes of health heart lung

vimarsana © 2020. All Rights Reserved.